Filing Flows › Denali Therapeutics (DNLI) › Recalls, complaints & regulation
Denali Therapeutics (DNLI): clinical trials
Denali Therapeutics (DNLI) beyond its filings: 9 active clinical trials.
Denali Therapeutics' latest quarter
Denali Therapeutics, Q3 2026: revenue $17.8M, operating margin -713.0%, net earnings $70.1M, operating cash flow −$117M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Denali Therapeutics have?
9 active studies on ClinicalTrials.gov, 2 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.